Relative Strength Chart Cardiol Therapeutics Inc.

Stocks

Market Closed - Toronto S.E. 16:00:00 2026-10-16 EDT			5-day change	1st Jan Change
1.580 ^CAD	-1.25%		-11.24%	+20.61%

09-23	Cardiol Therapeutics Achieves Phase III Maveric Enrollment Target Ahead of Schedule and Expands Pivotal Trial	CI
09-23	Cardiol Therapeutics Inc. Achieves MAVERIC Enrollment Target And Expands Pivotal Trial Evaluating CardiolRx	CI

End-of-day quotes

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	CARDIOL THERAPEUTICS INC.	Other Biotechnology & Medical Research	-1.25%	-11.24%	+20.61%	+8.22%	-67.42%	130M